Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X9SE
|
|||
| Drug Name |
US9359293, TB
|
|||
| Synonyms |
SCHEMBL18103198; CHEMBL3968962; BDBM234206; US9359293, TB
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C23H29N3O3S
|
|||
| Canonical SMILES |
CCCC(=S)NCCCCC(C(=O)NC1=CC=CC=C1)NC(=O)OC2=CC=CC=C2
|
|||
| InChI |
1S/C23H29N3O3S/c1-2-11-21(30)24-17-10-9-16-20(22(27)25-18-12-5-3-6-13-18)26-23(28)29-19-14-7-4-8-15-19/h3-8,12-15,20H,2,9-11,16-17H2,1H3,(H,24,30)(H,25,27)(H,26,28)
|
|||
| InChIKey |
WGKXXIZEWYTERA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | NAD-dependent deacetylase sirtuin-2 (SIRT2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | NAD-dependent deacetylase sirtuin-2 (SIRT2) | Target's Patent Info | [1] | |
| Pathway Interaction Database | Signaling events mediated by HDAC Class III | |||
| Signaling events mediated by HDAC Class I | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Methods of treatment using modulators of SIRT2. US9359293. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.